Cardiol Therapeutics Inc (CRDL) Live Share Price, Invest From India

Cardiol Therapeutics Inc Stock Performance

as on October 17, 2025 at 1:29 am IST

Day's High
$1.04
Day's Price Range
$1.08
$1.04
3.85%
Upside
52 Week's Low
52 Week's High
$0.77
52-Week Price Range
$2.24
$1.04
25.87%
Downside
115.38%
Upside

Cardiol Therapeutics Inc share price movements today

Previous Close: $1.08
Open: $1.08
Volume: 810.7K
Day's Low - High: $1.04 - $1.08
52 Week Low - High: $0.77 - $2.24

Cardiol Therapeutics Inc Historical Returns

1 Month Return: -3.7 %
3 Month Return: -12.61 %
1 Year Return: -46.39 %
3 Year Return: + 63.21 %
5 Year Return: 0 %

Cardiol Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cardiol Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$90.4M

EPS (TTM)

-0.415

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-40.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

141433900.00%

Cardiol Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiol Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cardiol Therapeutics Inc	BUY	$90.4M	NA	NA	0.00%
United Therapeutics Corporation	BUY	$19.6B	NA	16.88	40.36%
Haleon Plc Spon Ads	BUY	$40.9B	NA	20.42	13.81%
Neurocrine Biosciences Inc.	BUY	$13.6B	34.15%	40.81	13.88%
Zoetis Inc.	BUY	$63.5B	-12.41%	24.66	27.83%

Stock Returns calculator for Cardiol Therapeutics Inc Stock including INR - Dollar returns

The Cardiol Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cardiol Therapeutics Inc investment value today

Current value as on today

₹58,522

Returns

₹41,478

(-41.48%)

Returns from Cardiol Therapeutics Inc Stock

₹46,392 (-46.39%)

Dollar Returns*

₹4,914 (+4.91%)

Analyst Recommendation on Cardiol Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cardiol Therapeutics Inc. Average target price of $7.74

Cardiol Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cardiol Therapeutics Inc.

What analysts predicted

86.56%UPSIDE

Target Price

$7.74

Current Price

$1.04

Analyzed by

8 Analysts

Target

$7.74

Cardiol Therapeutics Inc target price $7.74, a slight upside of 86.56% compared to current price of $1.04. According to 8 analysts rating.

Cardiol Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Cardiol Therapeutics Inc Stock has increased by 36% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 17, 2025 to October 17, 2025

Change:36% versus previous 30 day period

Cardiol Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	0	0	-	-	-	-
Operating Income	-7	-4	-7	-8	-8	-7	-14	-9	-8	-7
EBITDA	-7	-6	-7	-	-8	-7	-13	-9	-8	-7
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-7	-5	-7	-9	-6	-12	-8	-8	-8
Income Tax Expense	0	1	-1	-	0	0	-	-	-	-
Net Income	-5	-5	-4	-5	-6	-4	-9	-5	-5	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cardiol Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	0	-	-	-
Gross Profit	0	0	0	0	0	0	-
Operating Income	-7	-13	-20	-45	-50	-29	-40
EBITDA	-7	-11	-20	-38	-41	-29	-40
Interest Expense	0	0	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-15	-13	-20	-31	-30	-28	-36
Income Tax Expense	0	0	0	-6	-10	0	-
Net Income	-11	-10	-16	-24	-22	-20	-25
Net Profit Margin	0.00%	0.00%	-26207.38%	-40170.45%	0.00%	0.00%	0.00%

Cardiol Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-5	-7	-9	-6	-12	-8	-8	-8
Operating Cash Flow	-5	-3	-6	-6	-4	-7	-5	-7	-4
Investing Cash Flow	0	0	-	0	0	0	0	0	0
Financing Cash Flow	0	0	0	0	0	0	18	0	0
Change in Cash	-4	-4	-6	-6	-4	-8	14	-7	-5

Cardiol Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024
Net Income	-15	-13	-20	-31	-30	-36
Operating Cash Flow	-10	-11	-9	-23	-27	-25
Investing Cash Flow	0	0	0	0	0	0
Financing Cash Flow	25	2	16	93	0	18
Change in Cash	14	-9	7	69	-24	-4

Global Institutional Holdings in Cardiol Therapeutics Inc

Funds	Holdings
Tejara Capital Ltd	3.9%
AdvisorShares Investments, LLC	1.02%
Lion Street Advisors, LLC	0.41%
Mmcap International Inc. Spc	0.35%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.	0.25%

See all

Insights on Cardiol Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CRDL has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 16.1% return, outperforming this stock by 62.5%
NEGATIVE IMPACT
Price Dip
In the last 1 year, CRDL stock has moved down by -46.4%

About Cardiol Therapeutics Inc

cardiol therapeutics is a nanotherapeutics company focused on the research and commercial development of proprietary drug formulations for the treatment of heart failure. heart failure is a chronic condition that affects more than 26 million people globally. over five million adults in the u.s. suffer from heart failure, and it remains a leading cause of death and hospitalization with associated healthcare costs exceeding $30 billion annually. people with heart failure experience shortness of breath, fatigue, rapid heart rate, edema, reduced exercise capacity and a marked reduction in quality of life. approximately half of all heart failure patients have heart failure with preserved ejection fraction (hfpef), which is often associated with diabetes, obesity and high blood pressure and for which there have been no new therapies developed in over 20 years. cardiol is developing ctx01, a proprietary nanoformulation of pharmaceutical cannabidiol for the treatment of hfpef. cannabidiol has

Organisation	Cardiol Therapeutics Inc
Headquarters	2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5
CEO	Mr. David G. Elsley MBA
E-voting on shares	Click here to vote

Key Management of Cardiol Therapeutics Inc

Name	Title
Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA	CFO, Corporate Secretary & Director
Mr. Bernard Lim B.Sc.	Chief Operating Officer
Dr. Andrew Warwick Hamer M.D.	Chief Medical Officer and Head of Research & Development
Trevor Burns	Investor Relations
Mr. John A. Geddes BSCPT, MBA	Vice President of Corporate Development
Mr. David G. Elsley MBA	President, CEO & Director

FAQs

What is Cardiol Therapeutics Inc share price today?

Cardiol Therapeutics Inc share price today is $1.04 as on October 17, 2025 at 1:29 am IST at the close of the market. Cardiol Therapeutics Inc share today touched a day high of $1.08 and a low of $1.04.

What is the 52 week high and 52 week low for Cardiol Therapeutics Inc share?

Cardiol Therapeutics Inc share touched a 52 week high of $2.24 on November 7, 2024 and a 52 week low of $0.77 on April 7, 2025. Cardiol Therapeutics Inc stock price today i.e. October 17, 2025 at 1:29 am IST is closed at $1.04,which is 53.57% down from its 52 week high and 34.91% up from its 52 week low.

What is Cardiol Therapeutics Inc's market capitalisation today?

Cardiol Therapeutics Inc market capitalisation is $0.00T as on October 17, 2025 at 1:29 am IST.

How to invest in Cardiol Therapeutics Inc Stock (CRDL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cardiol Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiol Therapeutics Inc Shares that will get you 1.4423 shares as per Cardiol Therapeutics Inc share price of $1.04 per share as on October 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cardiol Therapeutics Inc Stock (CRDL) from India?

Indian investors can start investing in Cardiol Therapeutics Inc (CRDL) shares with as little as ₹88.054 or $1 (as of October 17, 2025 at 6:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Cardiol Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 17, 2025 at 6:37 pm IST). Based on Cardiol Therapeutics Inc share’s latest price of $1.04 as on October 17, 2025 at 1:29 am IST, you will get 9.6154 shares of Cardiol Therapeutics Inc. Learn more about fractional shares .